Brown Advisory Securities, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Brown Advisory Securities, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 02, 2022	SELL	$548.35 - $738.84 $180,407 - $243,078	-329 Reduced 23.02%	1,100 $650,000
Q3 2020 Nov 13, 2020	SELL	$544.75 - $658.21 $438,523 - $529,859	-805 Reduced 36.03%	1,429 $800,000
Q1 2019 May 14, 2019	SELL	$372.08 - $439.57 $13,022 - $15,384	-35 Reduced 1.54%	2,234 $917,000
Q4 2018 Feb 13, 2019	SELL	$335.82 - $403.04 $13,768 - $16,524	-41 Reduced 1.77%	2,269 $843,000
Q3 2018 Nov 13, 2018	SELL	$351.14 - $408.51 $1,755 - $2,042	-5 Reduced 0.22%	2,310 $933,000
Q2 2018 Aug 03, 2018	SELL	$284.6 - $344.99 $284 - $344	-1 Reduced 0.04%	2,315 $797,000
Q1 2018 May 14, 2018	BUY	$315.82 - $393.78 $731,439 - $911,994	2,316 New	2,316 $796,000

1,484

83.7M

1.22M

1.5M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $76.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Brown Advisory Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Brown Advisory Securities, LLC with notifications on news.